Kaspi.kz Reports 60% Revenue Growth, 1% Net Income Increase in FY2025; Hepsiburada Acquisition Weighs on Profitability, Dividends Suspended

summarizeSummary

Kaspi.kz reported strong 60% revenue growth for FY2025, but net income increased by only 1% due to losses from the Hepsiburada acquisition and higher operating costs. The company suspended dividends for 2025 and excluded the acquired Hepsiburada from its internal control assessment, despite the subsidiary having material weaknesses.

check_boxKey Events

• Mixed Financial Performance for FY2025

  Consolidated revenue increased by 60% to KZT 4.05 trillion ($8.00 billion), but net income grew by only 1% to KZT 1.07 trillion ($2.11 billion) compared to the prior year. This weak bottom-line growth was significantly impacted by initial losses from the Hepsiburada acquisition.

• Hepsiburada Acquisition Impact

  The acquisition of a controlling stake in Turkish e-commerce platform Hepsiburada in January 2025 contributed KZT 1.02 trillion ($2.04 billion) to total revenue but resulted in a net loss of KZT 89.56 billion ($177 million) for the year, weighing heavily on overall profitability.

• Internal Control Weaknesses at Acquired Subsidiary

  The company's assessment of internal control over financial reporting for 2025 *excluded* Hepsiburada, which constituted 4% of total assets and 25% of total revenue. Hepsiburada had identified material weaknesses in its internal controls prior to the acquisition, raising significant governance concerns.

• Dividend Suspension and Future Intent

  Kaspi.kz paid no dividends in 2025, deviating from its historical policy of distributing at least 50% of net income. However, the company stated its intention to pay a quarterly dividend of KZT 850 per ADS in the future, subject to shareholder approval.

auto_awesomeAnalysis

This annual report provides a comprehensive overview of Kaspi.kz's financial performance and strategic developments for fiscal year 2025. While the company achieved robust 60% revenue growth, net income increased by only 1%, primarily due to the initial net losses from the Hepsiburada acquisition and increased operating expenses. The suspension of dividends in 2025, despite a historical policy of paying at least 50% of net income, is a notable negative signal. Furthermore, the disclosure that the company's internal control over financial reporting assessment *excluded* Hepsiburada, which itself had material weaknesses prior to acquisition and represents 25% of total revenue, raises significant corporate governance and risk concerns. This filing provides crucial context for the recent Form 144 insider sale by Director Vyacheslav Kim, indicating potential headwinds that may have influenced his decision to sell shares while the stock is near its 52-week low. Investors should closely monitor the integration and profitability of Hepsiburada, the impact of new regulatory changes in Kazakhstan, and the company's ability to restore net income growth and dividend payments.